Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06775106 · ClinicalTrials.gov registry record
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
A clinical trial of Critical Illness and Pulmonary Disease, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06775106: Recruiting study of Critical Illness and Pulmonary Disease, sponsored by Oregon Health and Science University.
NCT06775106 is a study of Critical Illness and Pulmonary Disease that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 100 participants, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06775106, a study of Critical Illness and Pulmonary Disease, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.
Primary Outcome
This platform leverages advanced breath sampling technology and a host-response-based assay to detect specific elevated neutrophil proteases during bacterial infections like VAP. The noninvasive approach provides a safer and more efficient alternative to methods like bronchoalveolar lavage (BAL). This approach can differentiate between bacterial colonization and active infection by capturing and analyzing exhaled breath, allowing clinicians to initiate more timely and targeted therapies, thereby
Conditions Studied
Interventions
- OTHER There is no intervention in this observational study
Study Locations (1)
Oregon
- Oregon Health and Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-11-30 |
| Est. Completion | 2026-12-31 |
What NCT06775106 shows while recruiting
NCT06775106 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,137-participant average among 91 other Critical Illness trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention in this observational study is the first listed.
NCT06775106 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06775106 about?
NCT06775106 is a clinical study titled "Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections". This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.
What is the current status of trial NCT06775106?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-11-30. Estimated completion is 2026-12-31.
What conditions does trial NCT06775106 study?
This clinical trial studies the following conditions: Critical Illness, Pulmonary Disease.
What interventions are being tested in trial NCT06775106?
The interventions under investigation include: There is no intervention in this observational study (OTHER).
Who is sponsoring clinical trial NCT06775106?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06775106 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06775106's enrollment target sits among peer trials
100 63rd of 91 higher than 24 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
RECRUITING · Phase 1
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI